MXPA02005604A - Aminobenzofenonas como inhibidores de il-1beta y tnf-alfa. - Google Patents
Aminobenzofenonas como inhibidores de il-1beta y tnf-alfa.Info
- Publication number
- MXPA02005604A MXPA02005604A MXPA02005604A MXPA02005604A MXPA02005604A MX PA02005604 A MXPA02005604 A MX PA02005604A MX PA02005604 A MXPA02005604 A MX PA02005604A MX PA02005604 A MXPA02005604 A MX PA02005604A MX PA02005604 A MXPA02005604 A MX PA02005604A
- Authority
- MX
- Mexico
- Prior art keywords
- group
- alkyl
- hydrogen
- alkoxycarbonyl
- alkylthio
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 4
- -1 hydroxy, mercapto Chemical group 0.000 abstract 4
- 125000001424 substituent group Chemical group 0.000 abstract 4
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 3
- 229910052736 halogen Inorganic materials 0.000 abstract 3
- 150000002367 halogens Chemical group 0.000 abstract 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 3
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 abstract 2
- 125000004455 (C1-C3) alkylthio group Chemical group 0.000 abstract 2
- 125000006274 (C1-C3)alkoxy group Chemical group 0.000 abstract 2
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 abstract 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 2
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 2
- 125000001183 hydrocarbyl group Chemical group 0.000 abstract 2
- 150000002431 hydrogen Chemical group 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000002950 monocyclic group Chemical group 0.000 abstract 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 2
- 125000000027 (C1-C10) alkoxy group Chemical group 0.000 abstract 1
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 abstract 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 239000005864 Sulphur Chemical group 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C325/00—Thioaldehydes; Thioketones; Thioquinones; Oxides thereof
- C07C325/02—Thioketones; Oxides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
- C07C225/22—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/32—Oximes
- C07C251/34—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- C07C251/48—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atom of at least one of the oxyimino groups bound to a carbon atom of a six-membered aromatic ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- AIDS & HIV (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16933399P | 1999-12-06 | 1999-12-06 | |
| PCT/DK2000/000653 WO2001042189A1 (en) | 1999-12-06 | 2000-11-29 | AMINOBENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA02005604A true MXPA02005604A (es) | 2004-09-10 |
Family
ID=22615235
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA02005604A MXPA02005604A (es) | 1999-12-06 | 2000-11-29 | Aminobenzofenonas como inhibidores de il-1beta y tnf-alfa. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US6541670B2 (enExample) |
| EP (1) | EP1237845B1 (enExample) |
| JP (1) | JP4684515B2 (enExample) |
| KR (1) | KR20020071876A (enExample) |
| CN (1) | CN1193003C (enExample) |
| AT (1) | ATE362912T1 (enExample) |
| AU (1) | AU776395B2 (enExample) |
| BR (1) | BR0016164A (enExample) |
| CA (1) | CA2393312C (enExample) |
| CZ (1) | CZ20021940A3 (enExample) |
| DE (1) | DE60034961T2 (enExample) |
| ES (1) | ES2287040T3 (enExample) |
| HU (1) | HUP0203813A3 (enExample) |
| MX (1) | MXPA02005604A (enExample) |
| NZ (1) | NZ519172A (enExample) |
| PL (1) | PL356049A1 (enExample) |
| RU (1) | RU2260422C2 (enExample) |
| WO (1) | WO2001042189A1 (enExample) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5763429A (en) * | 1993-09-10 | 1998-06-09 | Bone Care International, Inc. | Method of treating prostatic diseases using active vitamin D analogues |
| US6242434B1 (en) * | 1997-08-08 | 2001-06-05 | Bone Care International, Inc. | 24-hydroxyvitamin D, analogs and uses thereof |
| US20020128240A1 (en) * | 1996-12-30 | 2002-09-12 | Bone Care International, Inc. | Treatment of hyperproliferative diseases using active vitamin D analogues |
| US6566353B2 (en) * | 1996-12-30 | 2003-05-20 | Bone Care International, Inc. | Method of treating malignancy associated hypercalcemia using active vitamin D analogues |
| US6087350A (en) * | 1997-08-29 | 2000-07-11 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Use of pretreatment chemicals to enhance efficacy of cytotoxic agents |
| EP2340840B1 (en) * | 1998-03-27 | 2012-08-29 | Oregon Health Sciences University | Pulse dose Vitamin D drug for the treatment of hyperproliferative skin diseases |
| RU2270194C2 (ru) | 2000-05-22 | 2006-02-20 | Лео Фарма А/С | Бензофеноны как ингибиторы il-1бета и tnf-альфа, фармацевтическая композиция и способ лечения |
| IL153378A0 (en) | 2000-07-18 | 2003-07-06 | Bone Care Internat Inc | STABILIZED 1alpha-HYDROXY VITAMIN D |
| DE60115465T2 (de) | 2000-08-29 | 2006-08-03 | Nobex Corp. | Immunoregulierende verbindungen, deren derivate und ihre verwendung |
| US20020165286A1 (en) * | 2000-12-08 | 2002-11-07 | Hanne Hedeman | Dermal anti-inflammatory composition |
| GB0107368D0 (en) * | 2001-03-23 | 2001-05-16 | Novartis Ag | Organic compounds |
| KR100896667B1 (ko) * | 2001-08-28 | 2009-05-14 | 레오 파마 에이/에스 | 신규한 아미노벤조페논 및 이를 포함하는 약제학적 조성물 |
| US8048924B2 (en) * | 2001-08-29 | 2011-11-01 | Biocon Limited | Methods and compositions employing 4-aminophenylacetic acid compounds |
| DE60310730T2 (de) | 2002-07-09 | 2007-05-16 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmazeutische zusammensetzungen aus anticholinergica und p38 kinase hemmern zur behandlung von erkrankungen der atemwege |
| PL377377A1 (pl) * | 2002-12-20 | 2006-02-06 | Leo Pharma A/S | Nowe związki aminobenzofenonu |
| ZA200510137B (en) * | 2003-07-24 | 2007-04-25 | Leo Pharma As | Novel aminobenzophenone compounds |
| US20060003950A1 (en) * | 2004-06-30 | 2006-01-05 | Bone Care International, Inc. | Method of treating prostatic diseases using a combination of vitamin D analogues and other agents |
| US7094775B2 (en) * | 2004-06-30 | 2006-08-22 | Bone Care International, Llc | Method of treating breast cancer using a combination of vitamin D analogues and other agents |
| EP1773767B1 (en) | 2004-07-07 | 2016-03-09 | Biocon Limited | Synthesis of azo bonded immunoregulatory compounds |
| US20060035893A1 (en) | 2004-08-07 | 2006-02-16 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders |
| JP5015005B2 (ja) * | 2004-12-13 | 2012-08-29 | レオ ファーマ アクティーゼルスカブ | トリアゾール置換アミノベンゾフェノン化合物 |
| PE20060777A1 (es) | 2004-12-24 | 2006-10-06 | Boehringer Ingelheim Int | Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas |
| EP1992344A1 (en) | 2007-05-18 | 2008-11-19 | Institut Curie | P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation |
| EP2206534A1 (de) | 2008-10-09 | 2010-07-14 | c-a-i-r biosciences GmbH | Dibenzocycloheptanonderivate und pharmazeutische Mittel, welche diese Verbindungen enthalten |
| AU2010315547C1 (en) * | 2009-10-26 | 2015-06-04 | Société des Produits Nestlé S.A. | Assays for the detection of anti-TNF drugs and autoantibodies |
| WO2013100208A1 (ja) | 2011-12-28 | 2013-07-04 | 京都府公立大学法人 | 角膜内皮細胞の培養正常化 |
| US9353078B2 (en) | 2013-10-01 | 2016-05-31 | New York University | Amino, amido and heterocyclic compounds as modulators of rage activity and uses thereof |
| JP6730701B2 (ja) | 2013-11-14 | 2020-07-29 | 学校法人同志社 | 細胞増殖促進または細胞障害抑制による角膜内皮治療薬 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57177058A (en) | 1981-04-24 | 1982-10-30 | Hodogaya Chem Co Ltd | Novel fluoran compound |
| AU5921890A (en) * | 1989-06-13 | 1991-01-08 | Smithkline Beecham Corporation | Monokine activity interference |
| RU2037481C1 (ru) * | 1989-10-27 | 1995-06-19 | Американ Хоум Продактс Корпорейшн | Производные замещенной бензоилбензолбифенил- или 2-оксазолалкановой кислоты или их фармакологически приемлемые соли и способ их получения |
| JPH08104817A (ja) * | 1994-10-03 | 1996-04-23 | Nippon Soda Co Ltd | 新規なフルオラン化合物及びそれを用いた発色性記録材料 |
| GB9701453D0 (en) * | 1997-01-24 | 1997-03-12 | Leo Pharm Prod Ltd | Aminobenzophenones |
| EP1029851B1 (en) * | 1997-10-14 | 2005-04-20 | Mitsubishi Pharma Corporation | Piperazine compounds and medicinal use thereof |
| JPH11217387A (ja) * | 1998-01-27 | 1999-08-10 | Yamada Chem Co Ltd | フルオラン化合物及びこれを用いた発色性記録材料 |
| DK1202954T3 (da) * | 1999-07-16 | 2004-02-09 | Leo Pharma As | Nye aminobenzophenoner |
| RU2270194C2 (ru) * | 2000-05-22 | 2006-02-20 | Лео Фарма А/С | Бензофеноны как ингибиторы il-1бета и tnf-альфа, фармацевтическая композиция и способ лечения |
-
2000
- 2000-11-29 HU HU0203813A patent/HUP0203813A3/hu unknown
- 2000-11-29 CZ CZ20021940A patent/CZ20021940A3/cs unknown
- 2000-11-29 US US09/787,532 patent/US6541670B2/en not_active Expired - Lifetime
- 2000-11-29 AU AU16935/01A patent/AU776395B2/en not_active Ceased
- 2000-11-29 BR BR0016164-0A patent/BR0016164A/pt not_active IP Right Cessation
- 2000-11-29 PL PL00356049A patent/PL356049A1/xx not_active Application Discontinuation
- 2000-11-29 KR KR1020027007188A patent/KR20020071876A/ko not_active Ceased
- 2000-11-29 CN CNB008177767A patent/CN1193003C/zh not_active Expired - Fee Related
- 2000-11-29 DE DE60034961T patent/DE60034961T2/de not_active Expired - Lifetime
- 2000-11-29 CA CA2393312A patent/CA2393312C/en not_active Expired - Fee Related
- 2000-11-29 EP EP00979457A patent/EP1237845B1/en not_active Expired - Lifetime
- 2000-11-29 ES ES00979457T patent/ES2287040T3/es not_active Expired - Lifetime
- 2000-11-29 MX MXPA02005604A patent/MXPA02005604A/es active IP Right Grant
- 2000-11-29 WO PCT/DK2000/000653 patent/WO2001042189A1/en not_active Ceased
- 2000-11-29 NZ NZ519172A patent/NZ519172A/en not_active IP Right Cessation
- 2000-11-29 RU RU2002118113/15A patent/RU2260422C2/ru not_active IP Right Cessation
- 2000-11-29 JP JP2001543491A patent/JP4684515B2/ja not_active Expired - Fee Related
- 2000-11-29 AT AT00979457T patent/ATE362912T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2287040T3 (es) | 2007-12-16 |
| US6541670B2 (en) | 2003-04-01 |
| KR20020071876A (ko) | 2002-09-13 |
| CN1413186A (zh) | 2003-04-23 |
| JP2003516377A (ja) | 2003-05-13 |
| AU776395B2 (en) | 2004-09-09 |
| BR0016164A (pt) | 2002-08-13 |
| WO2001042189A1 (en) | 2001-06-14 |
| PL356049A1 (en) | 2004-06-14 |
| NZ519172A (en) | 2004-03-26 |
| HUP0203813A2 (hu) | 2003-03-28 |
| DE60034961T2 (de) | 2008-01-24 |
| RU2260422C2 (ru) | 2005-09-20 |
| CA2393312A1 (en) | 2001-06-14 |
| HK1053463A1 (en) | 2003-10-24 |
| JP4684515B2 (ja) | 2011-05-18 |
| CA2393312C (en) | 2011-07-12 |
| RU2002118113A (ru) | 2004-02-20 |
| US20030013770A1 (en) | 2003-01-16 |
| DE60034961D1 (de) | 2007-07-05 |
| ATE362912T1 (de) | 2007-06-15 |
| AU1693501A (en) | 2001-06-18 |
| EP1237845A1 (en) | 2002-09-11 |
| HUP0203813A3 (en) | 2008-03-28 |
| CN1193003C (zh) | 2005-03-16 |
| CZ20021940A3 (cs) | 2003-01-15 |
| EP1237845B1 (en) | 2007-05-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA02005604A (es) | Aminobenzofenonas como inhibidores de il-1beta y tnf-alfa. | |
| TWI266761B (en) | Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents | |
| PL353639A1 (en) | Aminobenzophenones as inhibitors of il-1beta and tnf-alpha | |
| WO2003077855A3 (en) | N3 alkylated benzimidazole derivatives as mek inhibitors | |
| MY127881A (en) | Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives | |
| NZ529874A (en) | Aromatic dicarboxylic acid derivatives useful as HDAC inhibitors | |
| NZ510180A (en) | Prodrugs of the pyridyl-methylsulphonyl-benzimidazole type proton pump inhibitors | |
| GEP20084341B (en) | Aminoheteroaryl compounds as protein kinase inhibitors | |
| NZ508990A (en) | Pyrazoline derivatives, their preparation and application as medicaments | |
| MX2009007050A (es) | Compuestos de carboxamida y su uso como inhibidores de calpaina. | |
| NO20044767L (no) | Farmasoytisk formulering med modifisert frigjoring | |
| DK1210320T3 (da) | Aminobenzofenoner som inhibitorer for IL-1beta og TNF-alfa | |
| PL353646A1 (en) | Aminobenzophenones as inhibitors of il-1beta and tnf-alpha | |
| GEP20053626B (en) | Substituted 8-Arylquinoline Phosphodiesterase-4 Inhibitors, Pharmaceutical Composition Containing Them and Use Thereof | |
| MXPA04009476A (es) | Compuestos de (tiazol-4,2-disustituidos-5-il)amina como inhibidores de la pde7. | |
| SE0302756D0 (sv) | Novel Compounds | |
| PL353645A1 (en) | Novel aminobenzophenones | |
| AP2002002466A0 (en) | 3-heterocycliylpropanohydroxamic acid PCP INHIBITORS. | |
| TW200735864A (en) | Immediate release pharmaceutical formulation | |
| IL152211A0 (en) | Alpha, beta-unsaturated sulfones for treating proliferative disorders | |
| WO2003068744A1 (en) | Pyridine derivatives or salts thereof and cytokine production inhibitors containing the same | |
| PL353644A1 (en) | Aminobenzophenones as inhibitors of il-1beta and tnf-alpha | |
| WO1995001170A3 (en) | Use of phenethanolamine derivatives in the treatment of gastrointestinal disorders | |
| CA2292775A1 (en) | Cyanoguanidines as cell proliferation inhibitors | |
| MXPA04009421A (es) | Compuestos de tiazol-2-ilimina como inhibidores de la pde-7. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |